Growth hormone deficiency: Diagnosis and therapy in childrenf

Mauro Bozzola, Cristina Meazza

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Growth hormone (GH) deficiency (GHD) represents a condition characterized by reduced GH secretion, isolated or associated with other pituitary hormone deficiencies. Diagnosis of GHD in childhood is achieved by secretagogs testing in combination with auxological parameters, such as height and growth velocity and biochemical and radiological findings. Only after excluding other causes of growth failure should a careful assessment of the pituitary-IGF-1 axis be undertaken, using GH-provocative tests and basal serum IGF-I values. As recommended by the GH Research Society, patients with GHD should be treated with recombinant human GH in order to normalize height during childhood and, ultimately, attain a normal adult height.

Original languageEnglish
Pages (from-to)273-284
Number of pages12
JournalExpert Review of Endocrinology and Metabolism
Volume5
Issue number2
DOIs
Publication statusPublished - Mar 2010

Fingerprint

Growth Hormone
Insulin-Like Growth Factor I
Therapeutics
Pituitary Hormones
Human Growth Hormone
Growth
Serum
Research

Keywords

  • Children
  • Growth hormone
  • Growth hormone deficiency
  • Growth hormone therapy
  • Short stature

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Cite this

Growth hormone deficiency : Diagnosis and therapy in childrenf. / Bozzola, Mauro; Meazza, Cristina.

In: Expert Review of Endocrinology and Metabolism, Vol. 5, No. 2, 03.2010, p. 273-284.

Research output: Contribution to journalArticle

@article{9960c2ab542043ac938d7696a6ca6eed,
title = "Growth hormone deficiency: Diagnosis and therapy in childrenf",
abstract = "Growth hormone (GH) deficiency (GHD) represents a condition characterized by reduced GH secretion, isolated or associated with other pituitary hormone deficiencies. Diagnosis of GHD in childhood is achieved by secretagogs testing in combination with auxological parameters, such as height and growth velocity and biochemical and radiological findings. Only after excluding other causes of growth failure should a careful assessment of the pituitary-IGF-1 axis be undertaken, using GH-provocative tests and basal serum IGF-I values. As recommended by the GH Research Society, patients with GHD should be treated with recombinant human GH in order to normalize height during childhood and, ultimately, attain a normal adult height.",
keywords = "Children, Growth hormone, Growth hormone deficiency, Growth hormone therapy, Short stature",
author = "Mauro Bozzola and Cristina Meazza",
year = "2010",
month = "3",
doi = "10.1586/eem.09.69",
language = "English",
volume = "5",
pages = "273--284",
journal = "Expert Review of Endocrinology and Metabolism",
issn = "1744-6651",
publisher = "Expert Reviews Ltd.",
number = "2",

}

TY - JOUR

T1 - Growth hormone deficiency

T2 - Diagnosis and therapy in childrenf

AU - Bozzola, Mauro

AU - Meazza, Cristina

PY - 2010/3

Y1 - 2010/3

N2 - Growth hormone (GH) deficiency (GHD) represents a condition characterized by reduced GH secretion, isolated or associated with other pituitary hormone deficiencies. Diagnosis of GHD in childhood is achieved by secretagogs testing in combination with auxological parameters, such as height and growth velocity and biochemical and radiological findings. Only after excluding other causes of growth failure should a careful assessment of the pituitary-IGF-1 axis be undertaken, using GH-provocative tests and basal serum IGF-I values. As recommended by the GH Research Society, patients with GHD should be treated with recombinant human GH in order to normalize height during childhood and, ultimately, attain a normal adult height.

AB - Growth hormone (GH) deficiency (GHD) represents a condition characterized by reduced GH secretion, isolated or associated with other pituitary hormone deficiencies. Diagnosis of GHD in childhood is achieved by secretagogs testing in combination with auxological parameters, such as height and growth velocity and biochemical and radiological findings. Only after excluding other causes of growth failure should a careful assessment of the pituitary-IGF-1 axis be undertaken, using GH-provocative tests and basal serum IGF-I values. As recommended by the GH Research Society, patients with GHD should be treated with recombinant human GH in order to normalize height during childhood and, ultimately, attain a normal adult height.

KW - Children

KW - Growth hormone

KW - Growth hormone deficiency

KW - Growth hormone therapy

KW - Short stature

UR - http://www.scopus.com/inward/record.url?scp=77949627396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77949627396&partnerID=8YFLogxK

U2 - 10.1586/eem.09.69

DO - 10.1586/eem.09.69

M3 - Article

AN - SCOPUS:77949627396

VL - 5

SP - 273

EP - 284

JO - Expert Review of Endocrinology and Metabolism

JF - Expert Review of Endocrinology and Metabolism

SN - 1744-6651

IS - 2

ER -